Sherlock BioSciences, an engineering biology company co-founded by Omar Abudayyeh, Ph.D. ’18 (bioengineering) recently launched with initial financing of $35 million.
The startup seeks to use engineering biology tools, including synthetic biology and CRISPR, to create a new generation of molecular diagnostics that can rapidly deliver accurate and inexpensive results. Abudayyeh is currently a Fellow at the McGovern Institute for Brain Research at MIT.
Sherlock’s technology is based on research conducted at Harvard’s Wyss Institute for Biologically Inspired Engineering and the Eli and Edythe L. Broad Institute of MIT and Harvard.
Share Your News
Have you made the headlines? Do you have news to share with your classmates and colleagues? Send your news items and photos to email@example.com.